Target intelligence / Profile preview

RNY3 pseudogene 15 (RNY3P15)

Target
RNY3P15
Molecular classification
Pseudogene, Non-coding RNA, Y RNA pseudogene
01

Overview

RNY3 pseudogene 15 (RNY3P15) is a human pseudogene classified as a non-coding RNA of the Y RNA family. Y RNAs are small non-coding RNAs, some of which (like the parental RNY3) are implicated in processes such as DNA replication and RNA processing, mainly by forming ribonucleoprotein complexes. However, RNY3P15 itself is specifically listed as a pseudogene, not known to encode a functional RNA or protein product, and there is no evidence it directly mediates a biological function, participates in disease, or serves as a therapeutic target. Pseudogenes like RNY3P15 may theoretically act as competitive endogenous RNAs (ceRNAs) or sponges in gene regulation, but there is no current data specifically supporting such a function for RNY3P15. There are no known drugs, biomarker roles, or disease associations assigned to this pseudogene. Key context: - Pseudogenes are generally regarded as non-functional gene copies arising during evolution; occasionally, some manifest regulatory roles, but most are not transcribed or translated. - The functional RNY3 (not RNY3P15) participates in immune cell biology and RNA processing, but these properties do not extend to RNY3P15 by current evidence. - RNY3P15 is not a receptor, enzyme, or any conventional therapeutic target category. - If a non-coding RNA pseudogene has unanticipated function or disease relevance, such roles must be researched and experimentally validated; no such work is published for RNY3P15. In summary, RNY3 pseudogene 15 is a non-coding RNA pseudogene with no confirmed functional, pathological, or therapeutic significance.

Other names
RNA, Ro-associated Y3 pseudogene 15RNY3P15

Beyond the preview

Go deeper on RNY3 pseudogene 15 (RNY3P15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNY3 pseudogene 15 (RNY3P15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call